Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RDY
RDY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RDY News
Topicus Submits Revised Proposal to Acquire ReadyTech
3h ago
Globenewswire
Topicus Submits Revised Proposal to Acquire ReadyTech
3h ago
Yahoo Finance
Australian Stock Market Shows Signs of Recovery
9h ago
Yahoo Finance
NYSE Issues Daily Pre-Market Advisory
2d ago
PRnewswire
Dr. Reddy's to Launch Generic Ozempic in Canada Soon
May 12 2026
seekingalpha
Dr. Reddy's Q4 Earnings Miss Expectations
May 12 2026
seekingalpha
Major Earnings Reports Expected Before Tuesday: JD, SE, and More
May 12 2026
seekingalpha
Dr. Reddy's First to Receive Marketing Authorization for Generic Semaglutide Injection in Canada
Apr 29 2026
Newsfilter
Dr. Reddy's Laboratories Seeks FDA Approval for Orencia Biosimilar
Feb 20 2026
seekingalpha
Dr. Reddy's Submits Biosimilar Application for Review
Feb 20 2026
Businesswire
Dr. Reddy's Submits Biosimilar Application for Abatacept
Feb 20 2026
Newsfilter
Dr. Reddy's Submits Biosimilar Application for Abatacept
Feb 20 2026
Yahoo Finance
Dr. Reddy's Receives USFDA Approval to Review Biologics License Application for Proposed Interchangeable Biosimilar Abatacept
Feb 20 2026
moomoo
Coya Therapeutics Secures $11.1 Million in Private Placement
Jan 30 2026
Yahoo Finance
Dr. Reddy's Laboratories (RDY) Reports Q3 EPS of ₹14.52 and Revenue of ₹87.27 Billion
Jan 22 2026
seekingalpha
Dr. Reddy's Laboratories (RDY) Secures Approval for Generic Ozempic, Plans to Produce 12M Pens in First Year
Jan 21 2026
seekingalpha
Show More News
